Michael Bader got his PhD in Biology at the University of Freiburg, Germany and his professorship in Pharmacology at the Charite, University Medicine Berlin, Germany. He is group leader at the Max-Delbrück-Center for Molecular Medicine (MDC), Berlin, where his research focusses on the functional analysis of cardiovascular hormones using molecular biological and transgenic animal technologies. He is in the Editorial Board of Hypertension and author of more than 200 publications.